Skip to main content

BNTX · BioNTech SE · Analyst Estimates

Track BNTX — free
$98.30 -0.27 (-0.27%) At close · Sep 30
Market Cap
$24.76B
Shares
251.20M
Volume · Sep 30 845.55K Avg daily vol (3M) 1.15M

Analyst Estimates

Compare analyst forecasts for BioNTech SE across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-25 07:45 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
-6.60846
-4.65458
-3.3
—
-4.96569
-4.26177
-4.65458
-4.60427
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
6
1
1
0
Revenue
EUR
Publication date not stated
1653000000
1806878610
2157000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
-6.7
-4.91294
-3.06557
—
-4.86183
-4.3281
-4.91294
-4.42584
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
4
0
2
1
Revenue
EUR
Publication date not stated
1156000000
1811045430
2432000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
17
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
0.39
0.75668
1.3548
—
0.75668
0.65699
0.75668
0.65699
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
0
0
3
3
Revenue
EUR
Publication date not stated
849000000
1063831690
1208000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
-2.19179
-0.75369
0.11
—
-0.79369
-0.83607
-0.75369
-0.83607
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
1
1
2
2
Revenue
EUR
Publication date not stated
346000000
503375650
683000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —
Key facts CIK 1776985 CUSIP 09075V102 13F (30d) 6 filings 6 filers Visit website Investor relations